Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05431127 · ClinicalTrials.gov registry record · NA
High Dose Inspiratory Muscle Training in LOPD
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05431127: Completed NA study, sponsored by Duke University.
NCT05431127 is a NA study that has completed, run by Duke University. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05431127, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Study Objectives: 1) assess the safety and feasibility of high-dose inspiratory muscle training (IMT) delivered remotely in Late-onset Pompe Disease (LOPD) and 2) determine its effects on respiratory and patient-reported outcomes.
Primary Outcome
Change pre-test to post test, measured in cm H20
Interventions
- DEVICE IMT therapy using the Pr02 mobile device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the finished NCT05431127 record still lists
NCT05431127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which IMT therapy using the Pr02 mobile device is the first listed.
NCT05431127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05431127 about?
NCT05431127 is a clinical study titled "High Dose Inspiratory Muscle Training in LOPD". Study Objectives: 1) assess the safety and feasibility of high-dose inspiratory muscle training (IMT) delivered remotely in Late-onset Pompe Disease (LOPD) and 2) determine its effects on respiratory and patient-reported outcomes.
What is the current status of trial NCT05431127?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-07-19. Estimated completion is 2025-01-01.
What interventions are being tested in trial NCT05431127?
The interventions under investigation include: IMT therapy using the Pr02 mobile device (DEVICE).
Who is sponsoring clinical trial NCT05431127?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05431127's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI